ACE2 and chronic obstructive pulmonary disease: Because the expression of ACE-2 is increased in patients with hypertension, diabetes, and chronic obstructive pulmonary disease (COPD), these comorbidities can increase both the risk and severity of COVID-19 infection29,30.